USPTO serial 75130689
ARTHROGEN-CIA
Reviewed by CopyMark Law Group
Reg. 2075589Status 710
- Filing date
- Status date
- Registration date
- Jul 1, 1997
- Examiner
- CALDERON, ANNA
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ARTHROGEN-CIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | purified collagen for research use; antibodies for in vitro scientific or research use; kits comprised of chemical reagents for testing of antibodies and enzymes for research purposes | SECTION 8 - CANCELLED | Jun 20, 1996 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CHONDREX LLC
- Other trademarks owned by CHONDREX, Inc.
- Other trademarks owned by CHONDREX LLC
- Other trademarks owned by CHONDREX LLC
- Other trademarks in Class 001
- Similar marks named ARTHROGEN-CIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 1, 2020 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Sep 11, 2007 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 11, 2007 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Aug 31, 2007 | PLGL | ASSIGNED TO PARALEGAL | — |
| Aug 9, 2007 | 89AF | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | — |
| Aug 9, 2007 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Nov 30, 2006 | CFIT | CASE FILE IN TICRS | — |
| Jan 21, 2006 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 21, 2006 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jun 30, 2003 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jun 30, 2003 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 1, 1997 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 8, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 3, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 1997 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Jan 28, 1997 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 11, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 1996 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Dec 5, 1996 | DOCK | ASSIGNED TO EXAMINER | — |